Researchers are excited about the medication , a groundbreaking dual agonist showing promising data in clinical trials for weight loss . It acts by targeting both systems: GLP-1 and GIP, which , when https://diegocsbj978911.madmouseblog.com/21506024/the-new-prospect-for-size-loss